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Background. Celiac disease (CD) is closely associated with other autoimmune endocrine disorders, particularly autoimmune
thyroid disease. The aim of this study was to ﬁnd the frequency of celiac disease in patients with hypothyroidism in Guilan
province, north of Iran. Methods. A total of 454 consecutive patients with hypothyroidism underwent celiac serological tests
antiGliadinantibodies(AGA),antitissuetransglutaminaseantibodies(IgA-tTG)andantiendomysialantibodies(EMA-IgA).Small
intestinal biopsy was performed when any of celiac serological tests was positive. Results. Eleven (2.4%) patients were positive for
celiac serology, and two patients with documented villous atrophy were diagnosed with classic CD (0.4%; 95%). Two patients
with classic CD had Hashimoto’s thyroiditis (HT) (0.6%; 95%). Six (54.5%) of 11 were suﬀering from overt hypothyroidism and
45.5% from subclinical hypothyroidism. Six (54.5%) had HT, and 45.5% had nonautoimmune hypothyroidism. Conclusions.I n
this study, prevalence of CD was lower than other studies. Most of the patients with CD were suﬀering from HT, but there was no
signiﬁcant statistical relation between CD and HT.
1.Background
Celiac disease (CD) is an immune-mediated enteropathy
that develops in susceptible individuals upon ingestion of
gluten-containing diet [1]. The classic deﬁnition of CD
or gluten-sensitive enteropathy includes the following three
features: villous atrophy; symptoms of malabsorption such
as steatorrhea, weight loss, or other signs of nutrient or
vitamin deﬁciency; resolution of the mucosal lesions and
symptoms upon withdrawal of gluten-containing foods,
usually within a few weeks to months [2]. The classic
presentation of CD is a severe malabsorption syndrome with
diarrhea, steatorrhea, and weight loss and possess antibodies
against gliadin and especially tissue transglutaminase [2].
CD is closely associated with other autoimmune endocrine
disorders, particularly autoimmune thyroid disease [1].
Among autoimmune disorders, increased prevalence of CD
hasbeenfoundinpatientswithautoimmunethyroiddisease,
type 1 diabetes mellitus, autoimmune liver diseases, and
inﬂammatory bowel disease. Prevalence of CD was noted
to be 1% to 19% in patients with type 1 diabetes mellitus,
2% to 5% in autoimmune thyroid disorders and 3%
to 7% in primary biliary cirrhosis in prospective studies
[3]. The pathogenesis of coexistent autoimmune thyroid
disease and CD is not known [3]. The term autoimmune
thyroid disease encompasses a number of diﬀerent entities
characterized by varying degrees of thyroid dysfunction
and the presence of serum autoantibodies against thyroid
tissue-speciﬁc components, such as thyroglobulin (Tg) and
thyroid peroxidase (TPO) [4]. Hashimotos thyroiditis (HT)
is deﬁned by the presence of high serum thyroid antibody
concentrations (TG and/or TPO) [5]. Likewise, several
studiesreportedprevalence’srangingfrom10%to30%[6–9]
for autoimmune thyroid disease, and from 4 to 19% for2 Journal of Thyroid Research
HT in patients with CD [7–10]. Screening patients with
autoimmune thyroid disease for CD and vice versa can give
anaccurateperceptiontothisassociation[1].Earlydiagnosis
and treatment lead to decrease of some complications as
malabsorption, infertility, osteoporosis, and lymphoma in
high-risk patients and improve drug absorption in these
patients [5].
The purpose of this study is to determine the frequency
of CD in the hypothyroid patients of Guilan province, north
of Iran.
2. Patientsand Methods
This descriptive study was done on 454 patients (49 men and
405 women, 10–85 years old, with mean age 39.46.13.54yr)
during February 2008 and February 2010. The patients
were selected consecutively from endocrinology clinics of
Rasht, the center of Guilan province. Serologic tests for
celiac including EMA-IgA, IgA-tTG, and AGA-IgA were
requested. Serum IgA-tTG (AESKULISA Tt.G-A (7503)
Germany) and AGA-IgG (AESKULISA Glia-G Germany)
were measured by enzyme-linked immunosorbent assay
(ELISA), serum was diluted 1:100, and the results were
expressed in Dutch unites per milliliter (DU/ML) [22].
Serum EMA (Euroimmun Germany) was determined by
means of indirect immunoﬂuorescence on frozen section
of commercial slides of duodenum [5]. Seropositively was
deﬁned when one or more of measured antibody tests
were positive, and all patients with at least one positive
serologic test (EMA-IgA +, IgA-tTG >10DU/ML and AGA-
IgA >15DU/ML ) underwent upper endoscopy and at least
four biopsies of second part of duodenum. The biopsy
ﬁndings were classiﬁed by MARSH criteria (Table 1)[ 11].
HT was deﬁned by the presence of thyroid antibodies
and hypothyroidism (high TSH and anti-TPO+) [23]. Overt
hypothyroidism was deﬁned by fT4 = low, TSH > 10MU/L,
and subclinical hypothyroidism was deﬁned by fT4 = NL,
TSH = 5–10MU/L[ 24].
Small intestinal biopsies (at least 4 biopsies) were
obtained during upper gastrointestinal endoscopy from
second part of the duodenum with a spike forceps for
histology. An experienced pathologist did the evaluation
of all biopsied material according to the modiﬁed Marsh
classiﬁcation [25]. The study was approved by ethical
committee of Gastrointestinal and Liver Disease Research
Center (GLDRC) of Guilan University of Medical Science.
Flow diagram of the study is seen in Figure 1.
2.1. Statistical Analysis. T h ed a t aw e r ea n a l y z e db yc h i -
square test. Continuous data having normal distribution are
p r e s e n t e di nm e a n s± SD, and categorical data are presented
in frequency rate and percentage. For all statistical analyses,
a two-tailed P value <0.05 was considered signiﬁcant.
3. Results
In this study, of 454 hypothyroid patients, 11 patients had
positive serologic test for CD. Nine of them (81.8%) were
454 patients with
hypothyroidism
Positiveceliacserology
antibodies (IgA-tTG)
antibodies (AGA-IgA)
antibodies (EMA-IgA)
11(2.4%)
8(1.8%)
3(0.7%)
0(%)
Smallbowelhistology
(10 of 11 celiac seropositive patients)
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Marsh III
8(72.7%)
2(18.2%)
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patients with Marsh III
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Antitissue transglutaminase
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Figure 1: Flow diagram of patient recruitment and examination.
female, and the other two were male (18.2%). Six (54.5%)
of 11 were suﬀering from overt hypothyroidism and the
rest 5 patients (45.5%) from subclinical hypothyroidism.
Six (54.5%) had HT, and 5 (45.5%) had nonautoimmune
hypothyroidism. Three had positive AGA-IgA and 8 had
positive IgA-tTG. All of patients with positive serologic test
underwent duodenal biopsy except for one patient, among
these 10 patients, two patients (0.4%) relieved histologic
change of celiac in small intestine (MARSH III), one
with overt hypothyroidism and the other with subclinical
hypothyroidism, both of them had classic CD. One patient
with positive serologic test and iron deﬁciency anemia had
normal biopsy and she classiﬁed as atypical CD. Seven
patients with positive serologic test and normal biopsy had
no gastrointestinal complains and were classiﬁed as having
potential CD (Table 2).
4. Discussion
F o rm a n yy e a r s ,c e l i a cs p r u ew a sd e ﬁ n e db yas e to f
classic standards for diagnosis. However, the combination
of serologic, genetic, and histologic data has led to the
identiﬁcation of three other classes of CD.
Atypical or extraintestinal CD, where gastrointestinal
signs/symptoms are minimal or absent and a number of
other manifestations are present. Asymptomatic (silent) CD,
where the small intestinal mucosa is damaged and CD
autoimmunity can be detected by serology, but there are noJournal of Thyroid Research 3
Table 1: Modiﬁed marsh classiﬁcation of CD [11].
Marsh type Intraepithelial Lymphocytes per 100 Enterocytes Crypts Villi
0 <40 Normal Normal
1 >40 Normal Normal
2 >40 Increased Normal
3a >40 Increased Mild atrophy
3b >40 Increased Marked atrophy
3c >40 Increased Absent
Type 0: normal mucosa; CD highly unlikely.
Type 1 (Inﬁltrative lesion): seen in patients on a gluten-free diet (suggesting minimal amounts of gliadin are being ingested); patients with DH; and family
members of patients with CD. However, these patients need to be followed because they may convert to a type 3 lesion.
Type 2 (hyperplastic type): very rare; seen occasionally in DH.
Type 3 (destructive lesion): spectrum of changes seen in symptomatic CD.
Table 2: Clinical characteristics and symptoms in patients with positive serologic tests for CD.
Number Age years Sex Type of hypothyroidism Hashimoto thyroiditis Clinical symptom Positive test Biopsy ﬁndings
1 45 Female Overt + Flatus diarrhea TGA Marsh III
2 41 Female Subclinical + Flatus TGA Marsh III
3 23 Female Subclinical + IDA∗ TGA Normal
4 43 Female Subclinical + − TGA Normal
5 56 Female Subclinical −− TGA Normal
6 37 Female Subclinical −− AGA Normal
72 1 F e m a l eO v e r t + − TGA Normal
85 2 F e m a l eO v e r t −− TGA Normal
96 1 F e m a l eO v e r t −− TGA Normal
10 58 Male Overt + − AGA Normal
11 12 Male Subclinical −− AGA Not done
∗Iron deﬁciency anemia.
symptoms. Latent, where individuals possess genetic com-
patibility with CD and may also show positive autoimmune
serology that has a normal mucosa morphology and may or
may not be symptomatic [26].
Two variants of what has been called latent CD have been
identiﬁed: CD was present before, usually in childhood; the
patient recovered completely with a gluten-free diet, remain-
ing “silent” even when a normal diet was reintroduced.
About 20 percent of such patients continue to have latent
disease(asymptomaticwithnormalvillousarchitecture)into
adulthood, while the others redevelop variable degrees of
villous atrophy [27]. Latency may be transient, and thus
regular followup of such patients is warranted. A normal
mucosa was diagnosed at an earlier occasion while ingesting
a normal diet, but CD developed later [2].
Patients with potential CD have never had a biopsy
consistent with CD but show immunologic abnormalities
characteristicforthedisease,suchasapositiveimmunoglob-
ulin A antibody to endomysium, tissue transglutaminase
or increased intraepithelial lymphocytes (IELs) in the small
intestine [28].
In this study, the total prevalence of CD including classic,
atypical and potential in hypothyroid patients was 2.4% and
prevalence of classic CD in hypothyroid patients was 0.4%.
So the rate of prevalence in this study was lower than other
studies [8]. Most of the patients with CD were suﬀering
from HT, but there was no signiﬁcant statistical relation
between CD and HT; however, in Hadithi et al. study, there
is relation between HT and CD [5], summarized prevalence
of CD in hypothyroid patients in some studies (Table 3)
[12–18]. Conversely, there is also an increased prevalence of
immune-based disorders among patients with CD (Table 4)
[5, 7–9, 19–21]. Female sex predominance was seen patients
with celiac, but it was not signiﬁcant (P = 0.626), however
other reports show female sex predominance role in this
disease [28]. Of 454 hypothyroid patients 338, (74.4%)
had HT and the other 116 (25.6%) had nonautoimmune
hypothyroidism. Both of the patients with CD had HT,
one with subclinical hypothyroidism and the other with
overt hypothyroidism. This ﬁnding supports the association
between CD and autoimmune thyroid disease, but it was not
a signiﬁcant statistical relation (P = 0.408). All of the two
patients showed gastrointestinal complains (one with ﬂatus
andtheotherwithﬂatusanddiarrhea).Itisconsiderablethat
most of 11 patients with celiac including classic, atypical and
potential had minor or no symptom and it can be concluded
that the CD moves toward presenting minor gastrointestinal
symptoms or asymptomatic. It is suggestive that the pattern
of presentation of CD had altered over the past years [3]. At
present, it is considerable that many patients with CD are
asymptomatic [29]. The mean age of patients with CD was
43. 2.82 year; it was in agreement with previous reports [3].4 Journal of Thyroid Research
Table 3: Prevalence of celiac disease (CD) in autoimmune thyroid disease.
Authors (year of publication) Population screened Prevalence of CD
Valentino et al. (1999) [12] 150 autoimmune thyroid disease 3.3%
Berti et al. (2000) [13] 172 autoimmune thyroid disease 3.5%
Volta et al. (2001) [14] 220 autoimmune thyroid disease 3.2%
Larizza et al. (2001) [15] 90 pediatric autoimmune thyroid disease 7.8%
Meloni et al. (2001) [16] 297 autoimmune thyroid disease 4.4%
Mainardi et al. (2002) [17] 100 autoimmune thyroid disease 2%
Ch’ng et al. (2005) [18] 115 Graves’ disease 4.5%
Hadithi et al. (2007) [5] 104 Hashimoto’s thyroiditis 4.8%
Table 4: Thyroid dysfunction in celiac disease (CD).
Authors (year of publication) Population studied with CD Prevalence of thyroid dysfunction
Collin et al. (1994) [19]
355 AITD∗ (19) 5.4%
Autoimmune hypothyroidism (11) 3.1%
Graves’ disease (7) 2%
Counsell et al. (1994) [20] 107 Hyperthyroid (4) 3.7%
Hypothyroid (11) 10.3%
Velluzzi et al. (1998) [7] 47 Hypothyroid (2) 4.3%
Subclinical hypothyroid (3) 6.4%
Sategna-Guidetti et al. (2001) [9] 241 Hypothyroid (31) 12.9%
Hyperthyroid (3) 1.2%
Euthyroid AITD (39) 16.2%
Hakanen et al. (2001) [8]
79 AITD (11)13.9%
Graves’ disease (3) 3.8%
Hypothyroid (8) 10.1%
Subclinical thyroid disease (8) 10.1%
Carta et al. (2002) [21] 39 Subclinical hypothyroid (3) 7.7%
Hadithi et al. (2007) [5] 184 Euthyroid (10) 5%
Overt hypothyroidism (22) 12%
Subclinical hypothyroid (7) 3.8%
∗Autoimmune thyroid disease.
Against other studies [5], in this study, patients with CD
showed positive IgA-tTG and AGA more than positive EMA.
However, Hadithi et al. found that most of patients with
CD had positive EMA test [5]. The ﬁrst published article
about celiac disease in Iran is “High prevalence of CD in
apparently healthy Iranian blood donors” in which 2000
healthy blood donors have been evaluated by EMA- IgA
test; result of this study shows that prevalence of CD is 1
in 400 person [30]. In other study, prevalence of CD in
Sari’s adults has been evaluated in 2006; in this study, 1438
persons were tested for IgA-tTG and least prevalence of CD
wasdetermined1in120person[31].Presentstudyistheﬁrst
study in Iran which determines frequency of CD in patients
with hypothyroidism. The total prevalence of CD including
classic, atypical and potential in hypothyroid patients was
2.4%, and prevalence of classic CD in hypothyroid patients
was 0.4%. Most of the patients with positive serologic test for
CD had HT (54.5%) and overt hypothyroidism (54.5%).
5. Conclusion
Screening high-risk patients for CD, such as those with
autoimmune diseases, is a reasonable strategy given the
increased prevalence. Treatment of CD with a gluten-
free diet should reduce the recognized complications of
this disease and provide beneﬁts in both general health
and perhaps life expectancy. CD and hypothyroidism can
present with nonspeciﬁc symptoms. Thus, it is necessary
to identify and treat a coexisting autoimmune disorder in
ordertoadequatelymanagetheprimarydisorder.Finally,the
availability of serological screening tools and the possibility
to prevent complications like osteoporosis or lymphomaJournal of Thyroid Research 5
in unrecognized patients with CD favor the screening of
patients with HT for CD even in absence of symptoms.
Screening of high-risk groups such as those with autoim-
mune thyroid disease is a reasonable strategy.
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